Therapeutic directions for Parkinson's disease (Q28743874)

scientific article (publication date: 2010)

Language	Label	Description	Also known as
English	Therapeutic directions for Parkinson's disease	scientific article (publication date: 2010)

Statements

instance of

scholarly article

0 references

title

Therapeutic directions for Parkinson's disease (English)

0 references

1 reference

Ira Shoulson

1

0 references

language of work or name

English

0 references

publication date

2010

0 references

published in

Movement Disorders

0 references

volume

25 Suppl 1

0 references

issue

S1

0 references

page(s)

S152-4

0 references

cites work

TCH346 as a neuroprotective drug in Parkinson's disease: a double-blind, randomised, controlled trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

16 March 2017

Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

16 March 2017

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

3 June 2018

Plasma urate and risk of Parkinson's disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

3 June 2018

Inhibition of mitogen-activated protein kinase and stimulation of Akt kinase signaling pathways: Two approaches with therapeutic potential in the treatment of neurodegenerative disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

3 June 2018

DATATOP: a decade of neuroprotective inquiry. Parkinson Study Group. Deprenyl And Tocopherol Antioxidative Therapy Of Parkinsonism.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

3 June 2018

Decreased single-photon emission computed tomographic [123I]beta-CIT striatal uptake correlates with symptom severity in Parkinson's disease.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

3 June 2018

Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

27 November 2018

Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

27 November 2018

Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3110693

retrieved

27 November 2018

Experimental neurotherapeutics: leaps and bounds

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20187232

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20187232

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Translational and clinical science--time for a new vision

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/20187232

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

0 references

0 references

PubMed publication ID

20187232

0 references

ResearchGate publication ID

41579886

0 references

Therapeutic directions for Parkinson's disease (Q28743874)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Therapeutic directions for Parkinson's disease (Q28743874)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search